CJC-1295 is a long-acting compound that binds to albumin in the blood, allowing it to stay in the system for about 6-8 days after a single injection, leading to sustained increases in GH and IGF-1
Liver tissue from older donors, when exposed to plasma from younger donors, began synthesizing proteins at rates typical of much younger tissue
Patients who combine the peptide with proper nutrition and regular exercise consistently see the best outcomes
examples like 4 weeks on / 2 off
While some individuals report weight loss following these injections, other contributing factors are highly likely
require documentation of indication, dosing, and clinical response Biologics (IL-12/23 inhibitor): Ustekinumab (Stelara, J3357) FDA-approved for moderate-to-severe CD